💠💠Drug firm GlaxoSmithKline Pharmaceuticals Monday reported a 35% rise in its standalone profit to ₹113.54 crore for the first quarter ended 30 June.
The company had posted a net profit of ₹84.08 crore for the corresponding period previous fiscal, GlaxoSmithKline Pharmaceuticals said in a BSE filing.
Standalone total income of the company also rose to ₹818.78 crore for the quarter under consideration as against ₹753.66 crore in the same period a year ago.
Shares of GlaxoSmithKline Pharmaceuticals ended at ₹1182.65 per scrip on the BSE, up 0.78% from its previous close.
NEWS CREDIT MINT
Regards,
AMIT KONAR
Proprietor
KONAR TRADE TALK ™